Arizona State Retirement System’s Esperion Therapeutics ESPR Stock Holding History

Arizona State Retirement System’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18,147	Closed	-$28.9K	–	2195
2023 Q1	$28.9K	Buy	18,147 +2,185	+14%	+$11.3K	﹤0.01%	2212
2022 Q4	$99.4K	Buy	+15,962	New	+$114K	﹤0.01%	2106
2021 Q2	–	Sell	-7,709	Closed	-$216K	–	2232
2021 Q1	$216K	Buy	+7,709	New	+$227K	﹤0.01%	2000
2020 Q4	–	Sell	-7,916	Closed	-$294K	–	2092
2020 Q3	$294K	Buy	7,916 +2,056	+35%	+$81.4K	﹤0.01%	1600
2020 Q2	$301K	Buy	+5,860	New	+$245K	﹤0.01%	1425

Other funds holding ESPR

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Arizona State Retirement System's ESPR Position: Q2 2023 in Review

Arizona State Retirement System sold out of Esperion Therapeutics (ESPR) in Q2 2023, closing a stake of 18,147 shares — an estimated $28.9K sold.

Arizona State Retirement System first reported a position in ESPR in Q2 2020 and held it in 5 quarters. The position peaked at $301K in Q2 2020. 124 funds tracked by Wall St. Rank hold ESPR as of Q2 2023.

Arizona State Retirement System reported no remaining Esperion Therapeutics position as of Q2 2023 after selling out during the quarter.
Arizona State Retirement System sold 18,147 Esperion Therapeutics shares in Q2 2023, an estimated $28.9K.
Arizona State Retirement System first reported a position in Esperion Therapeutics in Q2 2020 and held it in 5 quarters.
Arizona State Retirement System's Esperion Therapeutics position peaked at $301K in Q2 2020.
124 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2023.

Based on Arizona State Retirement System's 13F filing for Q2 2023, filed 1 Aug 2023.